The current P/E ratio for Hologic stock as of Jul 16, 2025 is 26.72. This is calculated based on the TTM EPS of $2.39 and the stock price of $63.86 per share. The PE ratio has increased by 9% from its last 4 quarters average of 24.4.
The average historical PE ratio of Hologic for the last ten years is 30.1. The current price-to-earnings ratio of 26.72 is 11% less than the historical average. Analyzing the last ten years, HOLX's PE ratio reached its highest point in the Dec 2019 quarter at 163.63, when the price was $52.36 and the EPS was $0.32. The lowest point was recorded in the Jun 2021 quarter, when it reached 8.37 with a price of $65.89 and an EPS of $7.87.
Maximum annual increase: 208.47% in 2023
Maximum annual decrease: -79.04% in 2015
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 24.13 | -35.67% | $80.82 | $3.35 |
2023 | 37.51 | 208.47% | $69.4 | $1.85 |
2022 | 12.16 | 15.7% | $62.98 | $5.18 |
2021 | 10.51 | -30.76% | $76.48 | $7.28 |
2020 | 15.18 | N/A | $64.35 | $4.24 |
2019 | N/A | N/A | $49.61 | -$0.76 |
2018 | N/A | N/A | $40.98 | -$0.4 |
2017 | 13.59 | -58.29% | $36.69 | $2.7 |
2016 | 32.58 | -61.72% | $38.45 | $1.18 |
2015 | 85.11 | -79.04% | $40 | $0.47 |
2014 | 406 | N/A | $24.36 | $0.06 |
2013 | N/A | N/A | $20.91 | -$4.36 |
2012 | N/A | N/A | $20.22 | -$0.28 |
2011 | 26 | N/A | $15.6 | $0.6 |
2010 | N/A | N/A | $16.66 | -$0.24 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 25.66 | 12.74% | $61.32 | $2.39 |
Dec 2024 | 22.76 | -5.68% | $72.6 | $3.19 |
Sep 2024 | 24.13 | -4.13% | $80.82 | $3.35 |
Jun 2024 | 25.17 | -36.73% | $74.25 | $2.95 |
Mar 2024 | 39.78 | 18.04% | $77.96 | $1.96 |
Dec 2023 | 33.7 | -10.16% | $71.45 | $2.12 |
Sep 2023 | 37.51 | -9.2% | $69.4 | $1.85 |
Jul 2023 | 41.31 | 55.13% | $80.97 | $1.96 |
Apr 2023 | 26.63 | 40.97% | $80.7 | $3.03 |
Dec 2022 | 18.89 | 55.35% | $74.81 | $3.96 |
Sep 2022 | 12.16 | 2.7% | $62.98 | $5.18 |
Jun 2022 | 11.84 | -4.59% | $70.93 | $5.99 |
Mar 2022 | 12.41 | 9.53% | $76.05 | $6.13 |
Dec 2021 | 11.33 | 7.8% | $76.12 | $6.72 |
Sep 2021 | 10.51 | 25.57% | $76.48 | $7.28 |
You can ether set your own Fair P/E multiple or use one of the automatically calculated Fair P/E multiples.
PE Ratio is an attempt to estimate a fair PE ratio of a stock based on its earnings and growth rate.
This formula is a modified version of the classic Graham-Dodd Formula (V= EPS x (8.5+2g)), originally developed by Benjamin Graham, to calculate the fair price of a stock based on its earnings and growth rate.
The formula we have created is an adaptation of this approach, designed to maintain a balance between simplicity and growth sensitivity.
It is calculated using the following formula:
IF g < 5: Fair PE = b
IF g >= 5: Fair PE = m × g
Here’s what each part of the formula means:
g: Growth is calculated as the average of the three-year average EPS growth rate and the one-year EPS growth rate (annually). This approach provides a balanced measure of growth by factoring in both the long-term growth trend and the most recent annual growth performance. If one of the growth metrics is not available, the remaining metric is used to determine growth. The fair P/E value is capped at 100 to prevent distortions caused by extreme EPS growth rates, such as those resulting from large percentage increases from a low base.
m: This is the long term historical median PEG (Price/Earnings to Growth) ratio of the overall market. It serves as a benchmark, adjusting the Fair PE based on typical market conditions.
b: Base PE (static value set to 8). If the company's growth rate is less than 5, the Fair PE is set at a conservative baseline of 8. This is because declining companies generally deserve a lower PE ratio.
Fixed: The Fair PE ratio for all data points is calculated using a single, constant average EPS growth rate, determined based on the most recent period. This means that the same growth rate is applied to all historical data points. Dynamic: The Fair PE ratio for each historical data point is calculated using the trailing average EPS growth rate specific to that point in time. This means that for each data point, the corresponding trailing EPS growth rate is used, ensuring that the Fair PE ratio reflects the growth conditions that were relevant at that specific point in history.
The current PE ratio of HOLX is above its 5-year average, but it is under its 3 and 10-year averages.
When compared to its peers GE and BSX, HOLX's PE ratio is lower, but it is higher than JNJ's and ABT's. Hologic's PE ratio is trading below the peer average of 32.96.
Stock name | PE ratio | Market cap |
---|---|---|
ABT Abbott Laboratories | 15.63 | $210B |
JNJ Johnson & Johnson | 17.99 | $392.17B |
DGX Quest Diagnostics Inc | 20.99 | $18.77B |
TMO Thermo Fisher Scientific Inc | 24.95 | $160.99B |
HOLX Hologic Inc | 26.79 | $14.27B |
BDX Becton Dickinson & Co | 34.82 | $51.69B |
GE General Electric Co | 40.25 | $278.13B |
BSX Boston Scientific Corp | 75.81 | $154.78B |
HOLX's price to earnings ratio is 26.72 as of Jul 16, 2025.
Over the last 3 years, the average PE ratio for HOLX stock is 27.97.
Over the last 5 years, the average PE ratio for HOLX stock is 21.13.
Over the last ten years, the Dec 2019 quarter recorded the highest quarterly PE ratio at 163.63.
The current PE ratio of HOLX is 11% lower than the 10-year historical average.
The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Jul 16, 2025), Hologic's share price is $63.86. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $2.39. Therefore, Hologic's price to earnings ratio for today is 26.72. PE RATIO(26.72) = STOCK PRICE($63.86) / TTM EPS($2.39)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.